Human Reproduction, Vol. 19, No. 1, 81-84,
January 2004
© 2004 European Society of Human Reproduction and Embryology
Effects of misoprostol on uterine contractility following different routes of administration
Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institute/Hospital, S-171 76 Stockholm, Sweden
1 To whom correspondence should be addressed. e-mail: kristina.gemzell@kbh.ki.se
BACKGROUND: The effect of misoprostol administered by different routes on pregnant uterine contractility was investigated. METHODS: Thirty-two women with a pregnancy between 8 and 11 weeks of gestation requesting termination of pregnancy were recruited. Misoprostol was administered either orally (0.4 mg), vaginally (0.4 mg) or sublingually (0.2 or 0.4 mg) according to consecutive allocation. Intrauterine pressure was recorded using a Grass polygraph connected to a pressure transducer 30 min before misoprostol was given and for 4 h thereafter. At the end of the recording, suction curettage was performed. RESULTS: The first effect observed was an increase in uterine tonus, which occurred after a significantly shorter time following oral (7.8 min) and sublingual (10.7– 11.5 min) than after vaginal (19.4 min) treatment. The time to maximum tonus elevation was also significantly shorter (39.5, 47.1–51.7 and 62.2 min for the three groups respectively). Regular uterine contractions developed in all subjects following sublingual and vaginal administration but not after oral administration. The increase in uterine activity measured in Montevideo Units was significantly higher after 2 h and thereafter for sublingual and vaginal treatment than for oral misoprostol. CONCLUSIONS: Based on recording of uterine activity, sublingual misoprostol acts as rapidly as oral treatment, while development of contractions was similar to that seen following vaginal administration.
Key words: misoprostol/pregnancy/sublingual administration/uterine contractility
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. von Hertzen, G. Piaggio, D. Wojdyla, N. T. M. Huong, L. Marions, G. Okoev, A. Khomassuridze, A. Kereszturi, S. Mittal, R. Nair, et al. Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial Hum. Reprod., September 14, 2008; (2008) den328v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Saav, A. Aronsson, L. Marions, O. Stephansson, and K. Gemzell-Danielsson Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial Hum. Reprod., October 1, 2007; 22(10): 2647 - 2652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aronsson, C. Fiala, O. Stephansson, F. Granath, B. Watzer, H. Schweer, and K. Gemzell-Danielsson Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol Hum. Reprod., July 1, 2007; 22(7): 1912 - 1918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lalitkumar, M. Bygdeman, and K. Gemzell-Danielsson Mid-trimester induced abortion: a review Hum. Reprod. Update, January 1, 2007; 13(1): 37 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Fiala, A. Aronsson, F. Granath, O. Stephansson, H.W. Seyberth, B. Watzer, and K. Gemzell-Danielsson Pharmacokinetics of a novel oral slow-release form of misoprostol Hum. Reprod., December 1, 2005; 20(12): 3414 - 3418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Fiala, A. Aronsson, O. Stephansson, and K. Gemzell-Danielsson Effects of slow release misoprostol on uterine contractility in early pregnancy Hum. Reprod., September 1, 2005; 20(9): 2648 - 2652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hamoda, P. W. Ashok, G. M.M. Flett, and A. Templeton A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation Hum. Reprod., August 1, 2005; 20(8): 2348 - 2354. [Abstract] [Full Text] [PDF]
|
|